Quick Verdict
ARA-290
Risk
Half-life
~3 hours
Ovagen
Risk
Half-life
—
Side-by-Side Comparison
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
A modified erythropoietin peptide that activates tissue repair pathways without stimulating red blood cell production. Strong evidence for neuropathic pain and sarcoidosis.
Research Areas
About Ovagen
Liver-targeted peptide complex modulating hepatocyte gene expression. Supports liver cell regeneration, enzyme function normalization, and hepatic protein synthesis.
A short peptide bioregulator derived from liver tissue, developed by the Khavinson Institute. Studied for restoration of hepatic function, detoxification pathway support, and anti-aging effects on liver tissue.
Research Areas
Find Providers
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More longevity Comparisons
Browse all peptides →Educational research tools — not medical advice.